ALFA Filings
Every announcement, straight from the exchange
Every Gland Pharma management change announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Gland Pharma Limited announced the resignation of director Wenjie Zhang and the appointment of Xingli Wang as a Non-Executive Non-Independent Director effective October 1, 2026.
Gland Pharma Limited has appointed Mr. Deepak Sapra as the new Chief Executive Officer, effective from November 16, 2026.
Gland Pharma shareholders approved the reappointment of Udo Jahannes Vetter and the appointment of William Robert Keller as Independent Directors for five-year terms.
Independent Director Mr. Satyanarayana Murthy Chavali resigned due to potential conflict of interest. His departure effective June 15, 2026, ensures governance standards.
Gland Pharma Limited reappointed Ms. Naina Lal Kidwai as Independent Director for five years starting May 2026. The reappointment ensures leadership stability and strong corporate governance.